MASLD Research Center @ UCSD
Joined January 2021
- Tweets324
- Following48
- Followers305
- Likes236
Thank you, Dr. Cyrielle Caussy, for joining us from Lyon, France, to discuss the role of resmetirom in the endocrinology clinic!
@DrLoomba #MASHDAY2026 #MASH #MASLD #MASHEDUCATIONDAY
Dr. Eduardo Grunvald’s talk on the role of GLP-1 receptor agonists in obesity and type 2 diabetes, highlighting their impact on metabolic health.
@DrLoomba #MASHDAY2026 #MASH #MASLD #MASHEDUCATIONDAY
Dr. Irvine Vodkin’s talk on MASH, Cirrhosis, and Liver Transplantation. A very thorough discussion with valuable clinical perspectives. @DrLoomba #MASHDAY2026 #MASH #MASLD #MASHEDUCATIONDAY
Dr. Harpreet Bhatia’s talk on cardiovascular disease and lipid management in patients with MASLD and significant fibrosis. A valuable discussion on an important aspect of MASLD care. @DrLoomba #MASHDAY2026 #MASH #MASLD #MASHEDUCATIONDAY
Great talk by @MonicaTincopa on MASH, Disparities, and Liver Cancer. A fascinating discussion! @DrLoomba #MASHDAY2026 #MASH #MASLD #MASHEDUCATIONDAY
Dr. Cynthia Behling's talk on Patient Liver Biospy. An excellent look at the role of liver biopsy in patient care! @DrLoomba #MASHDAY2026 #MASH #MASLD #MASHEDUCATIONDAY
Great presentation by @AjmeraVeeral on Patient Presentation to Clinic: Application of Care Pathways. Really enjoyed learning about the application of care pathways in clinical practice! @DrLoomba #MASHDAY2026 #MASHEDUCATIONDAY #MASH #MASLD
Thank you, @DrHuangDQ, for recording your talk on the Natural History of MASLD and Disease Progression! Such an informative and insightful presentation. @DrLoomba #MASH #MASHDAY2026 #MASHEDUCATIONDAY #MASLD
Kicking off #MASHDAY2026 with Dr. Ajmera's talk on MASLD Pre-Test, Nomenclature and an Introduction to the MASLD Patient Journey. @DrLoomba @AjmeraVeeral #MASH #MASHEDUCATIONDAY
MASLD Research Center retweeted
Strong work Maria Mironova @UCSD_GI fellow
PREVALENCE AND RISK FACTORS ASSOCIATED WITH MASLD AND ADVANCED FIBROSIS AMONG OVERWEIGHT INDIVIDUALS: IMPLICATIONS FOR SCREENING GUIDELINES. ovid.com/10.14309/ajg.000000… @AASLDtweets @UCSDHealth @AmCollegeGastro @AmerGastroAssn @INASL_Liver
Please to share our article co-authored by @DrLoomba, ALG-055009 shows promise in reducing liver fat and improving lipid profiles in non-cirrhotic MASH patients with a favorable safety profile!
thelancet.com/journals/langa…
@UCSD_GI @LancetGastroHep
MASLD Research Center retweeted
New research - ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial
thelancet.com/journals/langa… @DrLoomba
#MASH #MASLD #LiverTwitter #MedTwitter
MASLD Research Center retweeted
Pleased to share our review on MetALD co-authored with @LuisAntonioDiaz @IsraelsenMads @PoseElisa - such a great pleasure working with them on this piece. @rabataller @QAnstee @AASLDtweets @BavenoCoop @EASLnews @UCSD_GI @Dr_Vijay_Shah @AmerGastroAssn
nature.com/articles/s41575-0…
MASLD Research Center retweeted
Efficacy and safety of zalfermin co-administered with semaglutide in stage 2-4 fibrosis in MASH sciencedirect.com/science/ar… @AASLDtweets @EASLnews @wonglaihung @DrHuangDQ @Rob__Brierley @MASLDResearch @mashtagconf @precisionliver
Excited to share the publication of our latest work in @LancetGastroHep evaluating zalfermin and semaglutide in patients with metabolic dysfunction-associated steatohepatitis (MASH) and advanced fibrosis.
🎉@DrLoomba and the entire study team!
MASLD Research Center retweeted
Proud that @UCSD_GI is ranked #1 globally in Research & Education in the latest U.S. News rankings powered by Clarivate. Testament to our incredible faculty, trainees, staff & collaborators driving innovation and impact every day.
usnews.com/education/best-gl…
MASLD Research Center retweeted
From AI-powered outreach to advancing maternal health equity, our Improvement Excellence Awards spotlight teams reimagining care—reducing no-shows, improving access, lowering postpartum readmissions and redirecting medical supplies to communities in need. health.ucsd.edu/news/feature…
MASLD Research Center retweeted
‼️Starting soon‼️
In recognition of Global #FattyLiver Day, join us for Liver Q&A webinar sponsored by @LiverCoalition
I will be discussing: Understanding, Identifying & Managing #MASLD and #MASH.
See you soon!
@MASLDResearch @UCSD_GI @AmCollegeGastro @AASLDFoundation
Registration is open for our Liver Q&A Webinar on understanding and managing MASLD/MASH (#fattyliverdisease). Featuring Dr. @MonicaTincopa and a special #GlobalFattyLiverDay panel with experts, public health, community leaders, and patient voices. Register: livercoalition.zoom.us/webin…
MASLD Research Center retweeted
Vitamin E dosing study (VEDS) in pts with metabolic... : Hepatology journals.lww.com/hep/abstrac…
Key take home pts-
1. Vit E 200 IU ⬇️ALT in those with ALT >= 60 in MASLD over 6 months
2. No change in LSM by VCTE over 6 months with Vit E @AASLDtweets @INASL_Liver @HEP_Journal
